Tudor Investment Corp’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,259
Closed -$500K 1930
2024
Q3
$500K Buy
22,259
+211
+1% +$4.74K ﹤0.01% 1232
2024
Q2
$460K Buy
+22,048
New +$460K ﹤0.01% 1212
2024
Q1
Sell
-22,071
Closed -$228K 1800
2023
Q4
$228K Buy
+22,071
New +$228K ﹤0.01% 1313
2023
Q3
Sell
-12,991
Closed -$130K 1795
2023
Q2
$130K Sell
12,991
-9,115
-41% -$91.1K ﹤0.01% 1414
2023
Q1
$196K Sell
22,106
-56
-0.3% -$497 ﹤0.01% 1383
2022
Q4
$243K Sell
22,162
-35
-0.2% -$384 ﹤0.01% 1317
2022
Q3
$289K Buy
22,197
+1,848
+9% +$24.1K 0.01% 1303
2022
Q2
$258K Sell
20,349
-2,200
-10% -$27.9K 0.01% 1299
2022
Q1
$316K Sell
22,549
-2,300
-9% -$32.2K 0.01% 1255
2021
Q4
$719K Buy
+24,849
New +$719K 0.01% 1029